Creekmur Asset Management »

Gain Therapeutics shares owned by Creekmur Asset Management

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Creekmur Asset Management from 13F filings

Historical chart of Creekmur Asset Management investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Creekmur Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Creekmur Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.9k 4.4k 1.78
2024-06-30 $5.7k 4.4k 1.28
2024-03-31 $17k 4.4k 3.77
2023-12-31 $15k 4.4k 3.27

More positions owned by Creekmur Asset Management

Global X Fds 1-3 Month T-bill (CLIP)
First Tr Exchng Traded Fd Vi Ft Vest Laddered (BUFR)
First Tr Exchng Traded Fd Vi Ft Vest Laddered (BUFD)
First Tr Exchng Traded Fd Vi Ft Vest Laddered (BUFQ)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Core Us Aggbd Et (AGG)
First Tr Exchange-traded First Tr Enh New (FTSM)
First Tr Exchange-traded Intermediate Dur (FIIG)
Caterpillar (CAT)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Apple (AAPL)

View all positions for Creekmur Asset Management

Top funds holding Gain Therapeutics

DME Capital Management
Gotham Asset Management
Hohimer Wealth Management
Geode Capital Management
Vanguard Group
Cable Car Capital
BlackRock
BlackRock
Jones Financial Companies, L.L
Renaissance Technologies
Northern Trust
Bridgeway Capital Management
State Street Corporation
Virtu Financial
Susquehanna International

View all funds holding Gain Therapeutics